CD44 and cancer: In addition, NF-κB downstream effectors, such as CCND1, CCNE2, MET, VEGFA, CD44 and CD133, contribute to cancer proliferation, metastasis and stemness [22–28], and their expression is regulated by PCDH1 (Fig. S4).